Rena Boyajian Charchian, PHARM.D.
Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist · Los Angeles, CA
Rena Boyajian Charchian, PHARM.D. is a pharmacist clinician (phc)/ clinical pharmacy specialist with a practice address in Los Angeles, California, and NPI 1487216388, issued on Jul 1, 2019. Check the license (California 55858, as entered in NPPES) with the California board that licenses this profession; the Medicare figures below come from public CMS files.
- Name
- Rena Boyajian Charchian
- Credential
- PHARM.D.
- Primary taxonomy
- Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist 1835P0018X
- License number
- 55858 CA
Self-reported in NPPES; status is on the state search - Practice location
- 1510 San Pablo St Ste 144, Los Angeles, CA 90033
- Phone
- (323) 442-5770
- Enumerated
- Jul 1, 2019
- Record last updated
- Jul 1, 2019 (not updated in 7 years: call before relying on the address or phone)
- Fax
- (323) 442-5790
- Entity
- Type 1 · individual
8 nearest pharmacist clinician (phc)/ clinical pharmacy specialist records → All 1,593 in California → Look up another NPI →
Also registered at 1510 San Pablo St Ste 144
A shared address usually means a shared clinic or building; it does not show who employs whom.
- Ayda BonyadiPharmacist1780527358
- Allison Chacon-O'Shea, PHARMDPharmacist1497367635
- Kyle Fischer, PHARMDPharmacist1427669506
- Sharis Ghazeri, PHARMDPharmacist Clinician (PhC)/ Clinical Pharmacy Specialist1588381222
- Elizabeth GonzalezPharmacist1083364368
- Nicki MashayekanPharmacist1891343539
Verify Rena Boyajian Charchian in five checks
- 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
- 2LicenseActive license and public ordersWhich California board licenses this profession
Search for license 55858Check the board - 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
- 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
- 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
Most of these Medicare Part D claims are vaccines, 100% of the cost of the top drugs
19 Medicare Part D claims for 17 beneficiaries, against an average of 253 among the 1,614 providers of this specialty who prescribed in Part D. Brand-name drugs were 100% of claims.
Most prescribed
Pharmacies often give vaccines under a standing order that names one clinician, and CMS counts every such claim under that clinician's NPI. These claims are therefore not a measure of this clinician's own prescribing.
- Arexvy13 claims
Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.
Rena Boyajian Charchian among 1,593 pharmacist clinician (phc)/ clinical pharmacy specialist records in California
Rena Boyajian Charchian, PHARM.D. is one of 1,593 pharmacist clinician (phc)/ clinical pharmacy specialist records with a practice address in California. 17% of them appear in a Medicare file (Part D prescribing, MIPS, Open Payments or Medicare group billing); this one does. Its NPI, issued in 2019, is newer than 71% of them.
- NPI issued2019 · 71% of these records are older, 24% newer
- In a Medicare fileYes · 17% of these records are
- In the CMS Doctors and Clinicians fileNo · under 1% of these records are
- Record last updated2019 · 67% of these records were not updated in five years or more
Source: CMS NPPES, file of Aug 9, 2026, every record with primary taxonomy 1835P0018X and a California practice address; Medicare files: CMS Part D Prescribers 2024, MIPS 2023, Open Payments 2024, Doctors and Clinicians (data.cms.gov).
Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist providers in California
There are 1,593 pharmacist clinician (phc)/ clinical pharmacy specialist records in California.
All 1,593 in California → Every provider in Los Angeles → Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist nationwide →
The 8 pharmacist clinician (phc)/ clinical pharmacy specialist records with the nearest ZIP codes
- Paul Beringer, PHARM.D.Los Angeles, CA 900331780941252
- Michelle Chu, PHARM.D.Los Angeles, CA 900331174838544
- David Chung, M.D., M.B.A.Los Angeles, CA 900331356723704
- Richard Dang, PHARMD, BCACPLos Angeles, CA 900331578990925
- Sharis Ghazeri, PHARMDLos Angeles, CA 900331588381222
- Karen Kim, PHARMDLos Angeles, CA 900331003319989
- Gladys Mitani, PHARM. D.Los Angeles, CA 900331902109721
- Roya Mohajer-Jasbi, PHARM.D.Los Angeles, CA 900331528315025
Common questions
What is Rena Boyajian Charchian, PHARM.D.'s NPI number?
Rena Boyajian Charchian, PHARM.D.'s National Provider Identifier (NPI) is 1487216388, issued on Jul 1, 2019. An NPI identifies a provider in billing; it is not a license.
Where is Rena Boyajian Charchian, PHARM.D. located?
The NPPES record lists a practice address at 1510 San Pablo St Ste 144, Los Angeles, CA, 90033. Phone: (323) 442-5770. Providers update this record themselves, so call before visiting.
How can I verify Rena Boyajian Charchian, PHARM.D.'s license?
NPPES lists California license number 55858, as entered by the provider. Search the California board that licenses this profession; the NPPES record confirms identity only.
How much does Rena Boyajian Charchian, PHARM.D. prescribe under Medicare Part D?
In 2024, Rena Boyajian Charchian, PHARM.D. had 19 Medicare Part D claims for 17 beneficiaries; the average among pharmacist clinician (phc)/ clinical pharmacy specialist prescribers was 253. Part D covers Medicare prescriptions only.
Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.
Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.